Table: Chugai Pharm -Q1 group results (IFRS)

Chugai Pharmaceutical

23/04/2020 09:00

Apr 23 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2020        Mar 31, 2019     Dec 31, 2020 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              179.42              154.29                     
                   (+16.3 pct)         (+4.7 pct)                   
  Operating           72.41               46.09                     
                   (+57.1 pct)         (+20.2 pct)                  
  Pretax
  Net                 51.53               35.03                     
                   (+47.1 pct)         (+25.6 pct)                  
  EPS Basic         94.11 yen           64.01 yen                   
  EPS Diluted       93.99 yen           63.91 yen                   
  Ann Div                              140.00 yen                   
  -Q2 Div                               48.00 yen        75.00 yen  
  -Q4 Div                               92.00 yen        25.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T